These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7781522

  • 1. [Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas].
    Daus H, Trümper L, Bürger B, Jacobs G, Kriener S, von Blohn G, Zeitz M, Pfreundschuh M.
    Dtsch Med Wochenschr; 1995 Jun 09; 120(23):821-5. PubMed ID: 7781522
    [Abstract] [Full Text] [Related]

  • 2. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
    Dillon DA, Johnson CC, Topazian MD, Tallini G, Rimm DL, Costa JC.
    Cancer J; 2000 Jun 09; 6(5):294-301. PubMed ID: 11079168
    [Abstract] [Full Text] [Related]

  • 3. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
    Yamaguchi K, Chijiiwa K, Torato N, Kinoshita M, Tanaka M.
    Am J Gastroenterol; 2000 Aug 09; 95(8):1939-45. PubMed ID: 10950039
    [Abstract] [Full Text] [Related]

  • 4. [Restriction enzyme mismatch polymerase chain reaction in the demonstration of Ki-ras-oncogene mutation in carcinoma of the pancreas].
    Heller T, Trautmann B, Zöller-Utz I, König HJ, Liebe S, Ell C, Löhr M.
    Dtsch Med Wochenschr; 1995 Jun 09; 120(23):826-30. PubMed ID: 7781523
    [Abstract] [Full Text] [Related]

  • 5. Ki-ras codon 12 point mutation and p53 mutation in pancreatic diseases.
    Yamaguchi K, Chijiiwa K, Noshiro H, Torata N, Kinoshita M, Tanaka M.
    Hepatogastroenterology; 1999 Jun 09; 46(28):2575-81. PubMed ID: 10522044
    [Abstract] [Full Text] [Related]

  • 6. [Ki-ras mutation--a specific and sensitive tumor marker for carcinoma of the pancreas?].
    Schmid RM, Adler G.
    Dtsch Med Wochenschr; 1995 Jun 09; 120(23):830-3. PubMed ID: 7781524
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis.
    Löhr M, Müller P, Mora J, Brinkmann B, Ostwald C, Farré A, Lluis F, Adam U, Stubbe J, Plath F, Nizze H, Hopt UT, Barten M, Capellá G, Liebe S.
    Gastrointest Endosc; 2001 Jun 09; 53(7):734-43. PubMed ID: 11375580
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Detection of Ki-ras mutations by PCR and differential hybridization and of p53 mutations by SSCP analysis in endoscopically obtained lavage solution from patients with long-standing ulcerative colitis.
    Lang SM, Heinzlmann M, Stratakis DF, Teschauer W, Loeschke K.
    Am J Gastroenterol; 1997 Dec 09; 92(12):2166-70. PubMed ID: 9399746
    [Abstract] [Full Text] [Related]

  • 11. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH, van Mansfeld AD, Offerhaus GJ, van Weering DH, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL.
    Am J Pathol; 1993 Aug 09; 143(2):545-54. PubMed ID: 8342602
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.
    Uehara H, Nakaizumi A, Tatsuta M, Baba M, Takenaka A, Uedo N, Sakai N, Yano H, Iishi H, Ohigashi H, Ishikawa O, Okada S, Kakizoe T.
    Am J Gastroenterol; 1999 Sep 09; 94(9):2513-8. PubMed ID: 10484017
    [Abstract] [Full Text] [Related]

  • 13. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
    Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ, Kern SE.
    Cancer Res; 1994 Jul 01; 54(13):3568-73. PubMed ID: 8012983
    [Abstract] [Full Text] [Related]

  • 14. [Combined detection of K-ras mutation and CA 19-9 level in plasma of patients with pancreatic cancer].
    Dai MH, Zhao YP, Cai LX, Zhu Y.
    Zhonghua Wai Ke Za Zhi; 2003 May 01; 41(5):332-5. PubMed ID: 12892584
    [Abstract] [Full Text] [Related]

  • 15. [Sensitive detection of K-ras oncogene codon 12 mutations by nested PCR using mismatched primers and selective digestion of non-mutated PCR fragments with restriction enzyme].
    Fukayama N, Sugano K, Kyogoku A, Nose H, Kondou H, Ohkura H.
    Rinsho Byori; 1993 Sep 01; 41(9):1017-23. PubMed ID: 8254964
    [Abstract] [Full Text] [Related]

  • 16. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: comparison with K-ras mutation.
    Yamaguchi Y, Watanabe H, Yrdiran S, Ohtsubo K, Motoo Y, Okai T, Sawabu N.
    Clin Cancer Res; 1999 May 01; 5(5):1147-53. PubMed ID: 10353750
    [Abstract] [Full Text] [Related]

  • 17. [Detection of the Ki-ras mutation as a specific and sensitive marker of pancreatic carcinoma].
    Krechler T, Janda J, Dufek V, Kaláb M, Pesková M, Dorazilová V.
    Vnitr Lek; 1997 Oct 01; 43(10):678-81. PubMed ID: 9601883
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas.
    Mueller J, Gansauge S, Mattfeldt T.
    Hepatogastroenterology; 2003 Oct 01; 50(50):541-4. PubMed ID: 12749268
    [Abstract] [Full Text] [Related]

  • 20. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue].
    Cui Q, Wang Z, Chen J.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun 01; 16(3):201-5. PubMed ID: 7805165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.